Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,261 | -6,804 | -18,214 | -10,939 | -5,412 |
| Depreciation Amortization | 47 | 24 | -105 | 71 | 47 |
| Other Working Capital | -2,569 | 566 | 508 | -720 | -1,634 |
| Other Operating Activity | 696 | 355 | -5,688 | -6,226 | -6,558 |
| Operating Cash Flow | $-15,087 | $-5,859 | $-23,499 | $-17,814 | $-13,557 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,118 | 4,976 | -10,084 | -15,084 | -20,433 |
| Investing Cash Flow | $10,118 | $4,976 | $-10,084 | $-15,084 | $-20,433 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 532 | 531 | 424 |
| Other Financing Activity | 0 | 0 | 22,171 | 22,171 | 22,600 |
| Financing Cash Flow | $N/A | $N/A | $22,703 | $22,702 | $23,024 |
| Beginning Cash Position | 20,734 | 20,734 | 31,614 | 31,614 | 31,614 |
| End Cash Position | 15,765 | 19,851 | 20,734 | 21,418 | 20,648 |
| Net Cash Flow | $-4,969 | $-883 | $-10,880 | $-10,196 | $-10,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,087 | -5,859 | -23,499 | -17,814 | -13,557 |
| Free Cash Flow | -15,087 | -5,859 | -23,499 | -17,814 | -13,557 |